AbbVie (ABBV)’s Dividend Track Record: How It Became a Leader in Consistent Dividends

Core Insights - AbbVie Inc. (NYSE:ABBV) is recognized as one of the 13 Best Consistent Dividend Stocks to buy currently [1] - The company has shown strong performance in 2025, significantly outperforming the broader market, with a nearly 22% increase in stock price since the beginning of the year [2] - AbbVie has successfully transitioned away from its reliance on Humira, which lost US exclusivity in 2023, thanks to the strong sales growth of its autoimmune treatments Rinvoq and Skyrizi [3] - AbbVie boasts a remarkable dividend growth streak of 53 years, currently offering a quarterly dividend of $1.64 per share and a dividend yield of 3% as of September 12 [4]